Qube Research & Technologies (QRT)
CCCC icon

Qube Research & Technologies (QRT)’s C4 Therapeutics CCCC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Buy
752,114
+461,880
+159% +$1.09M ﹤0.01% 2184
2025
Q4 		$554K Buy
290,234
+174,261
+150% +$413K ﹤0.01% 2770
2025
Q3 		$257K Buy
+115,973
New +$278K ﹤0.01% 2887
2024
Q3 		– Sell
-258,426
Closed -$1.19M – 3384
2024
Q2 		$1.19M Sell
258,426
-129,767
-33% -$774K ﹤0.01% 1813
2024
Q1 		$3.17M Buy
388,193
+361,103
+1,333% +$2.8M 0.01% 1486
2023
Q4 		$153K Buy
27,090
+20,204
+293% +$46.1K ﹤0.01% 2935
2023
Q3 		$12.8K Sell
6,886
-69,896
-91% -$213K ﹤0.01% 3271
2023
Q2 		$211K Buy
76,782
+47,094
+159% +$151K ﹤0.01% 1761
2023
Q1 		$93.2K Buy
+29,688
New +$175K ﹤0.01% 2138

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return